Contact Next Edge Capital
1 Toronto Street, Suite 200
Toronto, ON M5C 2V6
Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta...
Eden Rahim, Portfolio Manager and Options Strategist, Next Edge Capital says the biotech sector in Canada is vastly underinvested and it contains a lot of opportunity. Rahim – who manages...
The current prime villain of Wall Street has shaken up the biotech space once again. Turing Pharmaceuticals AGCEO Martin Shkreli gained notorietyin September for raising the price of a parasitic-infection...